» Articles » PMID: 36644918

Informing Decision Makers About Public Preferences for Different Modalities of Cancer Treatment in the Rhône-Alps Region in France

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alternative options to hospital care like home care or local health centers (LHCs) are being advocated. However, no study has measured citizens' preferences (who will finance these services via taxation) for these options.

Objectives: We measured (i) citizens' preferences for these services, that is, respondents stated where they would like to get the treatment; (ii) the strength of their preference.

Methods: A computerized survey composed of (i) a decision aid to inform respondents about the three options; (ii) three scenarios, from light-to-heavy care, that respondents should rank from the most to the least preferred option of care. (iii) a contingent valuation survey (CVS) to assess how much respondents were willing to pay for their preferred option (except for hospital care if chosen, because it is the default option and free). (iv) a socio-demographic questionnaire.

Results: Data were collected from a representative sample of citizens living in the Rhône-Alps Region ( = 800). The heavier the care was, the more respondents preferred hospital care. Willingness to pay for additional taxation per household/month varied from €13.9 for light care in LHC to €19.1 for heavy home care. The small number of protesting respondents and outliers, and the close correlation between preferences, income, and WTP supports the validity of the CVS.

Conclusion: In France, for cancer, not all citizens would prefer to be treated at home rather than in a hospital. Only less than a quarter would prefer LHC. These results show the mismatch between public health policies and the citizens' preferences.

References
1.
Margier J, Gafni A, Moumjid N . Cancer care at home or in local health centres versus in hospital: Public policy goals and patients' preferences in the Rhône-Alps region in France. Health Policy. 2020; 125(2):213-220. DOI: 10.1016/j.healthpol.2020.11.011. View

2.
Baker R, Currie G, Donaldson C . What needs to be done in contingent valuation: have Smith and Sach missed the boat?. Health Econ Policy Law. 2010; 5(Pt 1):113-21. DOI: 10.1017/s174413310999003x. View

3.
Shepperd S, Goncalves-Bradley D, Straus S, Wee B . Hospital at home: home-based end-of-life care. Cochrane Database Syst Rev. 2016; 2:CD009231. PMC: 7111432. DOI: 10.1002/14651858.CD009231.pub2. View

4.
Smith R, Sach T . Contingent valuation: (still) on the road to nowhere?. Health Econ. 2009; 18(8):863-6. DOI: 10.1002/hec.1527. View

5.
Elwyn G, OConnor A, Stacey D, Volk R, Edwards A, Coulter A . Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006; 333(7565):417. PMC: 1553508. DOI: 10.1136/bmj.38926.629329.AE. View